| Primary |
| Hepatocellular Carcinoma |
50.0% |
| Nutritional Supplementation |
50.0% |
|
| Hospitalisation |
33.3% |
| Arthrodesis |
16.7% |
| Fatigue |
16.7% |
| Surgery |
16.7% |
| Trichorrhexis |
16.7% |
|
| Secondary |
| Product Used For Unknown Indication |
22.6% |
| Diabetes Mellitus |
9.7% |
| Depression |
6.5% |
| Fibromyalgia |
6.5% |
| Supplementation Therapy |
6.5% |
| Plasma Cell Myeloma |
5.4% |
| Postoperative Care |
5.4% |
| Arthritis |
4.3% |
| Blood Cholesterol Increased |
4.3% |
| Epilepsy |
4.3% |
| Atrial Fibrillation |
3.2% |
| Hepatitis C |
3.2% |
| Irritable Bowel Syndrome |
3.2% |
| Antioxidant Therapy |
2.2% |
| Anxiety |
2.2% |
| Bladder Irritation |
2.2% |
| Blood Potassium Decreased |
2.2% |
| Colitis |
2.2% |
| Drug Use For Unknown Indication |
2.2% |
| Fluid Replacement |
2.2% |
|
| Weight Decreased |
10.3% |
| Muscle Spasms |
6.9% |
| Nausea |
6.9% |
| Stomatitis |
6.9% |
| Temperature Intolerance |
6.9% |
| Therapeutic Response Decreased |
6.9% |
| Urticaria |
6.9% |
| Vomiting |
6.9% |
| Blood Glucose Increased |
3.4% |
| Blood Potassium Decreased |
3.4% |
| Cardiac Failure Congestive |
3.4% |
| Diabetes Mellitus |
3.4% |
| Drug Hypersensitivity |
3.4% |
| Exposure During Pregnancy |
3.4% |
| Frequent Bowel Movements |
3.4% |
| Haematochezia |
3.4% |
| Hepatic Cirrhosis |
3.4% |
| Hepatic Enzyme Increased |
3.4% |
| Hepatocellular Injury |
3.4% |
| Hypothyroidism |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.8% |
| Drug Use For Unknown Indication |
12.9% |
| Rheumatoid Arthritis |
4.7% |
| Hypertension |
4.5% |
| Vitamin Supplementation |
4.2% |
| Pain |
4.1% |
| Supplementation Therapy |
3.4% |
| Crohn's Disease |
2.8% |
| Multiple Sclerosis |
2.4% |
| Depression |
2.2% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Prophylaxis |
2.1% |
| Osteoporosis |
2.1% |
| Blood Cholesterol Increased |
1.7% |
| Atrial Fibrillation |
1.7% |
| Diabetes Mellitus |
1.6% |
| Asthma |
1.5% |
| Hepatitis C |
1.4% |
| Medical Diet |
1.4% |
| Anxiety |
1.3% |
|
| Vomiting |
14.8% |
| Weight Decreased |
11.1% |
| Nausea |
6.7% |
| Weight Increased |
6.4% |
| Pain |
6.2% |
| Urinary Tract Infection |
5.0% |
| Rash |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Death |
4.1% |
| Drug Ineffective |
4.0% |
| Pneumonia |
3.9% |
| Pulmonary Embolism |
3.9% |
| Pain In Extremity |
3.8% |
| Pyrexia |
3.4% |
| Vision Blurred |
3.4% |
| Tremor |
3.3% |
| Pruritus |
3.2% |
| Injection Site Pain |
3.1% |
| Off Label Use |
2.7% |
| Product Quality Issue |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Product Used For Unknown Indication |
50.0% |
|
|
